4.8 Article

Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling

Journal

CANCER RESEARCH
Volume 74, Issue 18, Pages 5019-5031

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-13-2845

Keywords

-

Categories

Funding

  1. Industry Fellowship Grant from Australian National Health and Medical Research Council (NHMRC)
  2. Ludwig Institute for Cancer Research
  3. Wellcome Trust Travelling Fellowship
  4. Lord Kelvin Adam Smith Fellowship from the University of Glasgow
  5. Ministerio de Educacion, Cultura y Deporte [AP2009-4324, AP2010-0795]
  6. Ministerio de Economia y Competitividad [SAF2012-33180]
  7. Comunidad de Madrid [S2010/BMD-2420]
  8. Instituto de Salud Carlos III [RD12/0019/0007]
  9. Medical Research Council [G0701437] Funding Source: researchfish
  10. MRC [G0701437] Funding Source: UKRI

Ask authors/readers for more resources

Natural killer (NK) cells are critical for innate tumor immunity due to their specialized ability to recognize and kill neoplastically transformed cells. However, NK cells require a specific set of cytokine-mediated signals to achieve optimal effector function. Th1-associated cytokines promote effector functions that are inhibited by the prototypic Th2 cytokine IL4 and the TGF beta superfamily members TGF beta 1 and activin-A. Interestingly, the largest subgroup of the TGF beta superfamily are the bone morphogenetic proteins (BMP), but the effects of BMP signaling on NK cell effector functions have not been evaluated. Here, we demonstrate that blood-circulating NK cells express type I and II BMP receptors, BMP-2 and BMP-6 ligands, and phosphorylated isoforms of Smad-1/-5/-8, which mediate BMP family member signaling. In opposition to the inhibitory effects of TGF beta 1 or activin-A, autocrine BMP signaling was supportive to NK cell function. Mechanistic investigations in cytokine and TLR-L-activated NK cells revealed that BMP signaling optimized IFN gamma and global cytokine and chemokine production, phenotypic activation and proliferation, and autologous dendritic cell activation and target cytotoxicity. Collectively, our findings identify a novel auto-activatory pathway that is essential for optimal NK cell effector function, one that might be therapeutically manipulated to help eradicate tumors. (C)2014 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available